K. Abiraj

Targeting Tumor-Associated Macrophages with Anti-CSF-1R Antibody Reveals a Strategy for Cancer Therapy

Carola H. Ries, Michael A. Cannarile, Sabine Hoves et al. · Cancer Cell · 2014 · 1.3K citations

Cancer Therapy, Tumor Biology, Tumor-associated Macrophages +12

CSF1R inhibition with emactuzumab in locally advanced diffuse-type tenosynovial giant cell tumours of the soft tissue: a dose-escalation and dose-expansion phase 1 study

Philippe A. Cassier, Antoîne Italiano, Carlos Gomez-Roca et al. · The Lancet Oncology · 2015 · 356 citations

Medicine, Immunology, Pathology +9

PET of Somatostatin Receptor–Positive Tumors Using ⁶⁴Cu- and ⁶⁸Ga-Somatostatin Antagonists: The Chelate Makes the Difference

Melpomeni Fani, Luigi Del Pozzo, K. Abiraj et al. · Journal of Nuclear Medicine · 2011 · 255 citations

Bombesin Antagonist–Based Radioligands for Translational Nuclear Imaging of Gastrin-Releasing Peptide Receptor–Positive Tumors

K. Abiraj, Rosalba Mansi, Maria‐Luisa Tamma et al. · Journal of Nuclear Medicine · 2011 · 106 citations · Full text

Reductive cleavage of azo compounds catalyzed by commercial zinc dust using ammonium formate or formic acid

Shankare Gowda, K. Abiraj, D. Channe Gowda · Tetrahedron Letters · 2002 · 96 citations

Chemical Engineering, Azo Compounds, Engineering +6